ERBB2 and breast cancer: The authors concluded that both HER2DX tests (HER2Dx Risk Score and HER2Dx pCR likelihood score) provide accurate estimates of the risk of recurrence (HER2Dx Risk Score) and the likelihood to achieve a pCR (HER2Dx pCR score) in the early stage HER2+ BC [15].